100
Participants
Start Date
December 19, 2024
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
P. aeruginosa using in vitro and in vivo assays
This trial will entail collecting and screening stool samples obtained from critically ill patients for their virulence inducing capabilities on laboratory strains of P. aeruginosa using in vitro and in vivo assays. The investigators also plan to isolate strains of intestinal P. aeruginosa from stool samples to determine the prevalence of intestinal P. aeruginosa in a population of critically ill patients.
RECRUITING
The University of Chicago, Hyde Park
National Institutes of Health (NIH)
NIH
National Institute of General Medical Sciences (NIGMS)
NIH
University of Chicago
OTHER